CONA
LGND icon

Capital One National Association’s Ligand Pharmaceuticals LGND Stock Holding History

Capital One National Association’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$348K Sell
2,693
-192
-7% -$21.4K 0.03% 388
2018
Q1 		$297K Sell
2,885
-61
-2% -$6.03K 0.02% 430
2017
Q4 		$252K Buy
+2,946
New +$255K 0.02% 462

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital One National Association's LGND Position: Q2 2018 in Review

Capital One National Association reduced its Ligand Pharmaceuticals (LGND) stake by 6.7% in Q2 2018, selling an estimated $21.4K and leaving 2,693 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #388.

Capital One National Association first reported a position in LGND in Q4 2017 and has held it in 3 quarters since. 346 funds tracked by Wall St. Rank hold LGND as of Q2 2018.

  • Capital One National Association held 2,693 shares of Ligand Pharmaceuticals worth $348K as of Q2 2018.
  • Capital One National Association sold 192 Ligand Pharmaceuticals shares in Q2 2018, an estimated $21.4K.
  • Ligand Pharmaceuticals made up 0.03% of Capital One National Association's portfolio in Q2 2018, its #388 holding.
  • Capital One National Association first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
  • 346 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.